Screening of single nucleotide polymorphism in CD95 (APO-1/FAS) promoter region (G-1377A) in children with acute leukemia
dc.contributor.author | Akin, Dilara F. | |
dc.contributor.author | Ozkan, Didem T. | |
dc.contributor.author | Kurekci, Emin | |
dc.contributor.author | Akar, Nejat | |
dc.date.accessioned | 2024-11-07T13:34:21Z | |
dc.date.available | 2024-11-07T13:34:21Z | |
dc.date.issued | 2018 | |
dc.department | Niğde Ömer Halisdemir Üniversitesi | |
dc.description.abstract | Background CD95 is a cell surface receptor involved in apoptotic signal transmission. Deregulation of this pathway results in downregulation of apoptosis and subsequent persistence of a malignant clone. A single nucleotide polymorphism resulting in guanine-to-adenine (G>A) transition in the CD95 promoter region (position - 1377) is thought to reduce stimulatory protein 1 transcription factor binding and decrease CD95 expression. The purpose of this study is to examine a genetic polymorphism in the core promoter region of CD95 and to evaluate association between its frequency and clinical findings. Patients and methods G-1377A in the CD95 promoter region was genotyped by polymerase chain reaction and restriction endonuclease analysis finally were sequenced by Sanger Sequecing. Results Among 146 patients, CD95 G-1377A (rs2234767) single nucleotide polymorphism carriers frequencies have been identified as 25% (n=37) GA and AA 4% (n=6). This polymorphism of the distribution of the CD95 gene in children with acute leukemia will be a guide for future studies. Conclusion This polymorphism of the distribution of the CD95 gene in children with acute leukemia will be a guide for future studies. (c) 2018 The Egyptian Journal of Haematology | |
dc.identifier.doi | 10.4103/ejh.ejh_55_17 | |
dc.identifier.endpage | 48 | |
dc.identifier.issn | 1110-1067 | |
dc.identifier.issn | 2090-9268 | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 45 | |
dc.identifier.uri | https://doi.org/10.4103/ejh.ejh_55_17 | |
dc.identifier.uri | https://hdl.handle.net/11480/15943 | |
dc.identifier.volume | 43 | |
dc.identifier.wos | WOS:000441639800001 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.language.iso | en | |
dc.publisher | Wolters Kluwer Medknow Publications | |
dc.relation.ispartof | Egyptian Journal of Haematology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.snmz | KA_20241106 | |
dc.subject | acute lymphoblastic leukemia | |
dc.subject | acute myeloblastic leukemia | |
dc.subject | CD95 polymorphism | |
dc.title | Screening of single nucleotide polymorphism in CD95 (APO-1/FAS) promoter region (G-1377A) in children with acute leukemia | |
dc.type | Article |